nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CYP3A4—bone cancer	0.309	0.505	CbGaD
Acetaminophen—PTGS2—bone cancer	0.302	0.495	CbGaD
Acetaminophen—PTGS2—Cisplatin—bone cancer	0.0347	0.342	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—bone cancer	0.0167	0.164	CbGbCtD
Acetaminophen—CYP2C9—Cisplatin—bone cancer	0.0118	0.116	CbGbCtD
Acetaminophen—ABCB1—Cisplatin—bone cancer	0.0114	0.113	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—bone cancer	0.00767	0.0755	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—bone cancer	0.00743	0.0732	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—bone cancer	0.00723	0.0712	CbGbCtD
Acetaminophen—TRPV1—trigeminal nerve—bone cancer	0.00595	0.339	CbGeAlD
Acetaminophen—CYP3A4—Doxorubicin—bone cancer	0.0046	0.0452	CbGbCtD
Acetaminophen—TRPV1—cranial nerve—bone cancer	0.00424	0.242	CbGeAlD
Acetaminophen—PTGS2—periosteum—bone cancer	0.00105	0.0598	CbGeAlD
Acetaminophen—PTGS2—leg—bone cancer	0.000835	0.0476	CbGeAlD
Acetaminophen—PTGS2—hindlimb—bone cancer	0.000746	0.0425	CbGeAlD
Acetaminophen—PTGS2—cartilage tissue—bone cancer	0.000734	0.0419	CbGeAlD
Acetaminophen—SULT1A1—tendon—bone cancer	0.000683	0.039	CbGeAlD
Acetaminophen—SULT1A1—spinal cord—bone cancer	0.000659	0.0376	CbGeAlD
Acetaminophen—PTGS2—appendage—bone cancer	0.00064	0.0365	CbGeAlD
Acetaminophen—TRPV1—spinal cord—bone cancer	0.00058	0.0331	CbGeAlD
Acetaminophen—Hypokalaemia—Epirubicin—bone cancer	0.000292	0.0027	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000289	0.00267	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000289	0.00267	CcSEcCtD
Acetaminophen—Hypotension—Cisplatin—bone cancer	0.000287	0.00266	CcSEcCtD
Acetaminophen—Abdominal discomfort—Methotrexate—bone cancer	0.000284	0.00263	CcSEcCtD
Acetaminophen—Muscular weakness—Epirubicin—bone cancer	0.000283	0.00262	CcSEcCtD
Acetaminophen—Pancytopenia—Methotrexate—bone cancer	0.000282	0.0026	CcSEcCtD
Acetaminophen—Abdominal distension—Epirubicin—bone cancer	0.000279	0.00258	CcSEcCtD
Acetaminophen—Asthma—Epirubicin—bone cancer	0.000278	0.00257	CcSEcCtD
Acetaminophen—Neutropenia—Methotrexate—bone cancer	0.000277	0.00256	CcSEcCtD
Acetaminophen—Dysuria—Methotrexate—bone cancer	0.000277	0.00256	CcSEcCtD
Acetaminophen—Dyspnoea—Cisplatin—bone cancer	0.000274	0.00253	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Methotrexate—bone cancer	0.000271	0.0025	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—bone cancer	0.00027	0.0025	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000268	0.00247	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000268	0.00247	CcSEcCtD
Acetaminophen—Decreased appetite—Cisplatin—bone cancer	0.000267	0.00247	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Cisplatin—bone cancer	0.000265	0.00245	CcSEcCtD
Acetaminophen—Drowsiness—Methotrexate—bone cancer	0.000264	0.00244	CcSEcCtD
Acetaminophen—Pancytopenia—Epirubicin—bone cancer	0.000264	0.00244	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000262	0.00242	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—bone cancer	0.000262	0.00242	CcSEcCtD
Acetaminophen—Neutropenia—Epirubicin—bone cancer	0.00026	0.0024	CcSEcCtD
Acetaminophen—Dysuria—Epirubicin—bone cancer	0.00026	0.0024	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—bone cancer	0.000259	0.00239	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—bone cancer	0.000257	0.00237	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—bone cancer	0.000254	0.00234	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Epirubicin—bone cancer	0.000253	0.00234	CcSEcCtD
Acetaminophen—Feeling abnormal—Cisplatin—bone cancer	0.000253	0.00234	CcSEcCtD
Acetaminophen—Hyperglycaemia—Epirubicin—bone cancer	0.00025	0.00231	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—bone cancer	0.00025	0.00231	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—bone cancer	0.000248	0.00229	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—bone cancer	0.000247	0.00228	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000245	0.00227	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—bone cancer	0.000244	0.00225	CcSEcCtD
Acetaminophen—Body temperature increased—Cisplatin—bone cancer	0.000243	0.00225	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—bone cancer	0.00024	0.00222	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—bone cancer	0.00024	0.00222	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—bone cancer	0.000239	0.00221	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—bone cancer	0.000237	0.00219	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—bone cancer	0.000237	0.00219	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—bone cancer	0.000237	0.00219	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—bone cancer	0.000234	0.00217	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—bone cancer	0.000234	0.00217	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—bone cancer	0.000234	0.00216	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—bone cancer	0.000233	0.00215	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—bone cancer	0.000232	0.00214	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—bone cancer	0.000231	0.00214	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—bone cancer	0.000229	0.00212	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000227	0.0021	CcSEcCtD
Acetaminophen—Hypersensitivity—Cisplatin—bone cancer	0.000226	0.00209	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—bone cancer	0.000224	0.00208	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—bone cancer	0.000223	0.00206	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—bone cancer	0.000222	0.00205	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—bone cancer	0.000222	0.00205	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—bone cancer	0.000222	0.00205	CcSEcCtD
Acetaminophen—Asthenia—Cisplatin—bone cancer	0.000221	0.00204	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—bone cancer	0.00022	0.00204	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—bone cancer	0.00022	0.00203	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—bone cancer	0.000219	0.00203	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—bone cancer	0.000219	0.00202	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—bone cancer	0.000218	0.00202	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—bone cancer	0.000218	0.00201	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—bone cancer	0.000217	0.002	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—bone cancer	0.000215	0.00199	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—bone cancer	0.000214	0.00198	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—bone cancer	0.000214	0.00198	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—bone cancer	0.000214	0.00198	CcSEcCtD
Acetaminophen—Chills—Methotrexate—bone cancer	0.000213	0.00197	CcSEcCtD
Acetaminophen—Diarrhoea—Cisplatin—bone cancer	0.00021	0.00194	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—bone cancer	0.00021	0.00194	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—bone cancer	0.000208	0.00192	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—bone cancer	0.000208	0.00192	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—bone cancer	0.000207	0.00191	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—bone cancer	0.000207	0.00191	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—bone cancer	0.000207	0.00191	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—bone cancer	0.000206	0.00191	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—bone cancer	0.000206	0.00191	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—bone cancer	0.000206	0.0019	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—bone cancer	0.000206	0.0019	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—bone cancer	0.000203	0.00188	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—bone cancer	0.000203	0.00187	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—bone cancer	0.000202	0.00187	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—bone cancer	0.000202	0.00186	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—bone cancer	0.000202	0.00186	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—bone cancer	0.000201	0.00186	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—bone cancer	0.0002	0.00185	CcSEcCtD
Acetaminophen—Chills—Epirubicin—bone cancer	0.000199	0.00184	CcSEcCtD
Acetaminophen—Vomiting—Cisplatin—bone cancer	0.000195	0.00181	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—bone cancer	0.000195	0.0018	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—bone cancer	0.000195	0.0018	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—bone cancer	0.000194	0.0018	CcSEcCtD
Acetaminophen—Rash—Cisplatin—bone cancer	0.000194	0.00179	CcSEcCtD
Acetaminophen—Dermatitis—Cisplatin—bone cancer	0.000194	0.00179	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—bone cancer	0.000193	0.00179	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—bone cancer	0.000193	0.00179	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—bone cancer	0.000192	0.00178	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—bone cancer	0.000192	0.00177	CcSEcCtD
Acetaminophen—PTGS1—connective tissue—bone cancer	0.000191	0.0109	CbGeAlD
Acetaminophen—Anaemia—Methotrexate—bone cancer	0.000191	0.00177	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—bone cancer	0.000191	0.00176	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—bone cancer	0.000191	0.00176	CcSEcCtD
Acetaminophen—Tension—Epirubicin—bone cancer	0.00019	0.00175	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—bone cancer	0.000188	0.00174	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—bone cancer	0.000187	0.00172	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—bone cancer	0.000186	0.00172	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—bone cancer	0.000186	0.00172	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—bone cancer	0.000186	0.00172	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—bone cancer	0.000185	0.00171	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—bone cancer	0.000185	0.00171	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—bone cancer	0.000184	0.00171	CcSEcCtD
Acetaminophen—PTGS2—connective tissue—bone cancer	0.000183	0.0104	CbGeAlD
Acetaminophen—Nausea—Cisplatin—bone cancer	0.000183	0.00169	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—bone cancer	0.000182	0.00168	CcSEcCtD
Acetaminophen—Cough—Methotrexate—bone cancer	0.00018	0.00167	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—bone cancer	0.00018	0.00166	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—bone cancer	0.000179	0.00166	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—bone cancer	0.000179	0.00166	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—bone cancer	0.000179	0.00165	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—bone cancer	0.000179	0.00165	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—bone cancer	0.000179	0.00165	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—bone cancer	0.000178	0.00164	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—bone cancer	0.000176	0.00163	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—bone cancer	0.000176	0.00162	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000175	0.00162	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—bone cancer	0.000174	0.00161	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—bone cancer	0.000174	0.00161	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—bone cancer	0.000174	0.00161	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—bone cancer	0.000173	0.0016	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—bone cancer	0.000172	0.00159	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—bone cancer	0.000171	0.00158	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—bone cancer	0.00017	0.00157	CcSEcCtD
Acetaminophen—Cough—Epirubicin—bone cancer	0.000169	0.00156	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—bone cancer	0.000169	0.00156	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—bone cancer	0.000169	0.00156	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—bone cancer	0.000168	0.00155	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—bone cancer	0.000167	0.00154	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—bone cancer	0.000166	0.00153	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—bone cancer	0.000165	0.00153	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—bone cancer	0.000165	0.00153	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—bone cancer	0.000165	0.00153	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—bone cancer	0.000165	0.00152	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—bone cancer	0.000164	0.00152	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—bone cancer	0.000164	0.00152	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—bone cancer	0.000164	0.00151	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000164	0.00151	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—bone cancer	0.000163	0.00151	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—bone cancer	0.000163	0.0015	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—bone cancer	0.000161	0.00149	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—bone cancer	0.000161	0.00149	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—bone cancer	0.000161	0.00149	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—bone cancer	0.00016	0.00148	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—bone cancer	0.000159	0.00147	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—bone cancer	0.000158	0.00146	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—bone cancer	0.000158	0.00146	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—bone cancer	0.000158	0.00146	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—bone cancer	0.000158	0.00146	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—bone cancer	0.000156	0.00144	CcSEcCtD
Acetaminophen—Shock—Epirubicin—bone cancer	0.000155	0.00144	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—bone cancer	0.000155	0.00143	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—bone cancer	0.000155	0.00143	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—bone cancer	0.000155	0.00143	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—bone cancer	0.000155	0.00143	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—bone cancer	0.000154	0.00142	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—bone cancer	0.000153	0.00142	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—bone cancer	0.000153	0.00141	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—bone cancer	0.000153	0.00141	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—bone cancer	0.000152	0.00141	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—bone cancer	0.000152	0.0014	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000151	0.0014	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—bone cancer	0.000151	0.00139	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—bone cancer	0.00015	0.00139	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—bone cancer	0.00015	0.00139	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—bone cancer	0.00015	0.00139	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—bone cancer	0.000149	0.00138	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—bone cancer	0.000148	0.00137	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—bone cancer	0.000148	0.00136	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—bone cancer	0.000147	0.00136	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—bone cancer	0.000147	0.00136	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—bone cancer	0.000146	0.00135	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—bone cancer	0.000146	0.00135	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—bone cancer	0.000146	0.00135	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—bone cancer	0.000145	0.00134	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—bone cancer	0.000144	0.00133	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—bone cancer	0.000143	0.00132	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—bone cancer	0.000143	0.00132	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—bone cancer	0.000143	0.00132	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—bone cancer	0.000143	0.00132	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—bone cancer	0.000142	0.00131	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—bone cancer	0.000141	0.00131	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—bone cancer	0.000141	0.0013	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—bone cancer	0.00014	0.0013	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—bone cancer	0.000139	0.00129	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—bone cancer	0.000139	0.00128	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—bone cancer	0.000139	0.00128	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—bone cancer	0.000138	0.00128	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—bone cancer	0.000137	0.00127	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—bone cancer	0.000136	0.00126	CcSEcCtD
Acetaminophen—CYP2E1—tendon—bone cancer	0.000136	0.00778	CbGeAlD
Acetaminophen—Gastrointestinal disorder—Epirubicin—bone cancer	0.000136	0.00126	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—bone cancer	0.000136	0.00126	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—bone cancer	0.000135	0.00125	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—bone cancer	0.000134	0.00124	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—bone cancer	0.000133	0.00123	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—bone cancer	0.000133	0.00123	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—bone cancer	0.000132	0.00122	CcSEcCtD
Acetaminophen—CYP2E1—spinal cord—bone cancer	0.000132	0.0075	CbGeAlD
Acetaminophen—PTGS1—tendon—bone cancer	0.000131	0.00749	CbGeAlD
Acetaminophen—Dyspnoea—Doxorubicin—bone cancer	0.00013	0.0012	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—bone cancer	0.00013	0.0012	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—bone cancer	0.00013	0.0012	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—bone cancer	0.000129	0.00119	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—bone cancer	0.000129	0.00119	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—bone cancer	0.000127	0.00117	CcSEcCtD
Acetaminophen—PTGS1—spinal cord—bone cancer	0.000127	0.00723	CbGeAlD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000126	0.00117	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—bone cancer	0.000126	0.00116	CcSEcCtD
Acetaminophen—PTGS2—tendon—bone cancer	0.000126	0.00716	CbGeAlD
Acetaminophen—Urticaria—Epirubicin—bone cancer	0.000125	0.00116	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—bone cancer	0.000125	0.00115	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—bone cancer	0.000125	0.00115	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—bone cancer	0.000125	0.00115	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—bone cancer	0.000124	0.00115	CcSEcCtD
Acetaminophen—PTGS2—bone marrow—bone cancer	0.000122	0.00694	CbGeAlD
Acetaminophen—PTGS2—spinal cord—bone cancer	0.000121	0.00691	CbGeAlD
Acetaminophen—Asthenia—Methotrexate—bone cancer	0.000121	0.00112	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—bone cancer	0.00012	0.00111	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—bone cancer	0.000119	0.0011	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—bone cancer	0.000119	0.0011	CcSEcCtD
Acetaminophen—Hypersensitivity—Epirubicin—bone cancer	0.000116	0.00108	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—bone cancer	0.000116	0.00107	CcSEcCtD
Acetaminophen—CNR1—Signaling Pathways—GRM4—bone cancer	0.000116	0.000717	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—RGS1—bone cancer	0.000116	0.000717	CbGpPWpGaD
Acetaminophen—Abdominal pain—Doxorubicin—bone cancer	0.000115	0.00107	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—bone cancer	0.000115	0.00107	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—bone cancer	0.000115	0.00107	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—bone cancer	0.000113	0.00105	CcSEcCtD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000113	0.0007	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000113	0.0007	CbGpPWpGaD
Acetaminophen—Pruritus—Epirubicin—bone cancer	0.000112	0.00103	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—bone cancer	0.000112	0.00103	CcSEcCtD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000111	0.000687	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—GNA11—bone cancer	0.00011	0.000678	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—IL3—bone cancer	0.000109	0.000677	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—DHFR—bone cancer	0.000109	0.000676	CbGpPWpGaD
Acetaminophen—Diarrhoea—Epirubicin—bone cancer	0.000108	0.000998	CcSEcCtD
Acetaminophen—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000108	0.000667	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Doxorubicin—bone cancer	0.000108	0.000995	CcSEcCtD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000108	0.000665	CbGpPWpGaD
Acetaminophen—Vomiting—Methotrexate—bone cancer	0.000107	0.000991	CcSEcCtD
Acetaminophen—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000107	0.00066	CbGpPWpGaD
Acetaminophen—Rash—Methotrexate—bone cancer	0.000106	0.000983	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—bone cancer	0.000106	0.000982	CcSEcCtD
Acetaminophen—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000106	0.000654	CbGpPWpGaD
Acetaminophen—Headache—Methotrexate—bone cancer	0.000106	0.000977	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—CYP3A4—bone cancer	0.000105	0.000651	CbGpPWpGaD
Acetaminophen—Asthenia—Doxorubicin—bone cancer	0.000105	0.000969	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—bone cancer	0.000104	0.000965	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.000104	0.000641	CbGpPWpGaD
Acetaminophen—Pruritus—Doxorubicin—bone cancer	0.000103	0.000955	CcSEcCtD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000103	0.000638	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—GNA11—bone cancer	0.000102	0.000632	CbGpPWpGaD
Acetaminophen—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000102	0.000631	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000102	0.000631	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ENO2—bone cancer	0.000101	0.000627	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000101	0.000625	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—GRM1—bone cancer	0.000101	0.000621	CbGpPWpGaD
Acetaminophen—Vomiting—Epirubicin—bone cancer	0.0001	0.000928	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—bone cancer	0.0001	0.000926	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—bone cancer	9.99e-05	0.000924	CcSEcCtD
Acetaminophen—Rash—Epirubicin—bone cancer	9.95e-05	0.00092	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—bone cancer	9.94e-05	0.000919	CcSEcCtD
Acetaminophen—CNR1—Signaling by GPCR—IL3—bone cancer	9.94e-05	0.000614	CbGpPWpGaD
Acetaminophen—Headache—Epirubicin—bone cancer	9.89e-05	0.000914	CcSEcCtD
Acetaminophen—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	9.71e-05	0.0006	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ENO2—bone cancer	9.68e-05	0.000598	CbGpPWpGaD
Acetaminophen—Dizziness—Doxorubicin—bone cancer	9.66e-05	0.000893	CcSEcCtD
Acetaminophen—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	9.56e-05	0.000591	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	9.45e-05	0.000584	CbGpPWpGaD
Acetaminophen—CYP2E1—Biological oxidations—CYP3A4—bone cancer	9.43e-05	0.000583	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—DHFR—bone cancer	9.42e-05	0.000582	CbGpPWpGaD
Acetaminophen—Nausea—Epirubicin—bone cancer	9.38e-05	0.000867	CcSEcCtD
Acetaminophen—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	9.3e-05	0.000575	CbGpPWpGaD
Acetaminophen—Vomiting—Doxorubicin—bone cancer	9.29e-05	0.000858	CcSEcCtD
Acetaminophen—UGT1A1—Metabolism—NDUFA12—bone cancer	9.28e-05	0.000574	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—NDUFA12—bone cancer	9.28e-05	0.000574	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—CYP3A4—bone cancer	9.27e-05	0.000573	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.27e-05	0.000573	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.22e-05	0.00057	CbGpPWpGaD
Acetaminophen—Rash—Doxorubicin—bone cancer	9.21e-05	0.000851	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—bone cancer	9.2e-05	0.000851	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—bone cancer	9.15e-05	0.000846	CcSEcCtD
Acetaminophen—UGT2B15—Metabolism—ENO2—bone cancer	9.1e-05	0.000563	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.09e-05	0.000562	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.04e-05	0.000559	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—GSTP1—bone cancer	9e-05	0.000556	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—DHFR—bone cancer	8.98e-05	0.000555	CbGpPWpGaD
Acetaminophen—CYP1A1—Biological oxidations—CYP3A4—bone cancer	8.89e-05	0.00055	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—GNA11—bone cancer	8.8e-05	0.000544	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.78e-05	0.000543	CbGpPWpGaD
Acetaminophen—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	8.77e-05	0.000542	CbGpPWpGaD
Acetaminophen—Nausea—Doxorubicin—bone cancer	8.68e-05	0.000802	CcSEcCtD
Acetaminophen—UGT2B15—Metabolism—DHFR—bone cancer	8.45e-05	0.000522	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CDK4—bone cancer	8.4e-05	0.000519	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—GNA11—bone cancer	8.4e-05	0.000519	CbGpPWpGaD
Acetaminophen—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.29e-05	0.000512	CbGpPWpGaD
Acetaminophen—CYP2C8—Biological oxidations—CYP3A4—bone cancer	8.15e-05	0.000504	CbGpPWpGaD
Acetaminophen—CYP2E1—Biological oxidations—GSTP1—bone cancer	8.07e-05	0.000499	CbGpPWpGaD
Acetaminophen—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	8.04e-05	0.000497	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.02e-05	0.000496	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.02e-05	0.000496	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—CYP3A4—bone cancer	7.98e-05	0.000493	CbGpPWpGaD
Acetaminophen—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	7.96e-05	0.000492	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.94e-05	0.000491	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—GSTP1—bone cancer	7.93e-05	0.00049	CbGpPWpGaD
Acetaminophen—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	7.9e-05	0.000488	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—GNA11—bone cancer	7.89e-05	0.000488	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.88e-05	0.000487	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.7e-05	0.000476	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—NT5C3A—bone cancer	7.69e-05	0.000475	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—NT5C3A—bone cancer	7.69e-05	0.000475	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—CYP3A4—bone cancer	7.61e-05	0.00047	CbGpPWpGaD
Acetaminophen—CYP1A1—Biological oxidations—GSTP1—bone cancer	7.61e-05	0.00047	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ENO2—bone cancer	7.6e-05	0.00047	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—NDUFA12—bone cancer	7.57e-05	0.000468	CbGpPWpGaD
Acetaminophen—ABCB1—bone marrow—bone cancer	7.52e-05	0.00429	CbGeAlD
Acetaminophen—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	7.5e-05	0.000464	CbGpPWpGaD
Acetaminophen—ABCB1—spinal cord—bone cancer	7.49e-05	0.00427	CbGeAlD
Acetaminophen—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.49e-05	0.000463	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—RB1—bone cancer	7.3e-05	0.000451	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.22e-05	0.000446	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.17e-05	0.000443	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—NDUFA12—bone cancer	7.16e-05	0.000442	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—CYP3A4—bone cancer	7.16e-05	0.000442	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SMO—bone cancer	7.08e-05	0.000438	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—DHFR—bone cancer	7.05e-05	0.000436	CbGpPWpGaD
Acetaminophen—CYP2C8—Biological oxidations—GSTP1—bone cancer	6.97e-05	0.000431	CbGpPWpGaD
Acetaminophen—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	6.88e-05	0.000425	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—GSTP1—bone cancer	6.82e-05	0.000422	CbGpPWpGaD
Acetaminophen—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.75e-05	0.000417	CbGpPWpGaD
Acetaminophen—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.69e-05	0.000414	CbGpPWpGaD
Acetaminophen—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.64e-05	0.00041	CbGpPWpGaD
Acetaminophen—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.6e-05	0.000408	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—GNA11—bone cancer	6.59e-05	0.000407	CbGpPWpGaD
Acetaminophen—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.55e-05	0.000404	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.53e-05	0.000404	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—GSTP1—bone cancer	6.51e-05	0.000402	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.51e-05	0.000402	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—GNA11—bone cancer	6.48e-05	0.0004	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.44e-05	0.000398	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—NT5C3A—bone cancer	6.27e-05	0.000387	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—GSTP1—bone cancer	6.12e-05	0.000378	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.11e-05	0.000377	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ATF1—bone cancer	6.02e-05	0.000372	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NDUFA12—bone cancer	6.01e-05	0.000371	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CYP3A4—bone cancer	5.97e-05	0.000369	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—NT5C3A—bone cancer	5.93e-05	0.000366	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL3—bone cancer	5.87e-05	0.000363	CbGpPWpGaD
Acetaminophen—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.78e-05	0.000357	CbGpPWpGaD
Acetaminophen—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.73e-05	0.000354	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.71e-05	0.000353	CbGpPWpGaD
Acetaminophen—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.68e-05	0.000351	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.67e-05	0.00035	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NDUFA12—bone cancer	5.66e-05	0.000349	CbGpPWpGaD
Acetaminophen—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.65e-05	0.000349	CbGpPWpGaD
Acetaminophen—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.6e-05	0.000346	CbGpPWpGaD
Acetaminophen—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.59e-05	0.000346	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.46e-05	0.000337	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.45e-05	0.000337	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NDUFA12—bone cancer	5.33e-05	0.000329	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—MMP9—bone cancer	5.27e-05	0.000325	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.12e-05	0.000316	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.12e-05	0.000316	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—GSTP1—bone cancer	5.11e-05	0.000316	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TGFBR2—bone cancer	5.02e-05	0.00031	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NT5C3A—bone cancer	4.98e-05	0.000308	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NDUFA12—bone cancer	4.89e-05	0.000302	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.85e-05	0.0003	CbGpPWpGaD
Acetaminophen—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.78e-05	0.000296	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IGF1R—bone cancer	4.73e-05	0.000292	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.7e-05	0.000291	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NT5C3A—bone cancer	4.69e-05	0.00029	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—bone cancer	4.66e-05	0.000288	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NT5C3A—bone cancer	4.42e-05	0.000273	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NDUFA12—bone cancer	4.26e-05	0.000263	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—EGFR—bone cancer	4.26e-05	0.000263	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.24e-05	0.000262	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—bone cancer	4.11e-05	0.000254	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.05e-05	0.00025	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NT5C3A—bone cancer	4.05e-05	0.00025	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NDUFA12—bone cancer	4.01e-05	0.000248	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NDUFA12—bone cancer	3.98e-05	0.000246	CbGpPWpGaD
Acetaminophen—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.74e-05	0.000231	CbGpPWpGaD
Acetaminophen—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.69e-05	0.000228	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.68e-05	0.000228	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—bone cancer	3.57e-05	0.000221	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—bone cancer	3.53e-05	0.000218	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NT5C3A—bone cancer	3.53e-05	0.000218	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KIT—bone cancer	3.43e-05	0.000212	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NDUFA12—bone cancer	3.4e-05	0.00021	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—bone cancer	3.37e-05	0.000208	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ENO2—bone cancer	3.37e-05	0.000208	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ENO2—bone cancer	3.37e-05	0.000208	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NT5C3A—bone cancer	3.33e-05	0.000205	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NT5C3A—bone cancer	3.3e-05	0.000204	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—BRAF—bone cancer	3.22e-05	0.000199	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—bone cancer	3.17e-05	0.000196	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—DHFR—bone cancer	3.13e-05	0.000193	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—DHFR—bone cancer	3.13e-05	0.000193	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—EGFR—bone cancer	3.12e-05	0.000193	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3e-05	0.000186	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GNA11—bone cancer	2.92e-05	0.000181	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GNA11—bone cancer	2.92e-05	0.000181	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.89e-05	0.000179	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.89e-05	0.000179	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NT5C3A—bone cancer	2.82e-05	0.000174	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ENO2—bone cancer	2.75e-05	0.00017	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MDM2—bone cancer	2.7e-05	0.000167	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CYP3A4—bone cancer	2.65e-05	0.000164	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CYP3A4—bone cancer	2.65e-05	0.000164	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—bone cancer	2.65e-05	0.000164	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.63e-05	0.000163	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NDUFA12—bone cancer	2.62e-05	0.000162	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.61e-05	0.000161	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ENO2—bone cancer	2.6e-05	0.000161	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ENO2—bone cancer	2.6e-05	0.000161	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—DHFR—bone cancer	2.55e-05	0.000157	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.43e-05	0.00015	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—DHFR—bone cancer	2.42e-05	0.000149	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—DHFR—bone cancer	2.41e-05	0.000149	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GNA11—bone cancer	2.38e-05	0.000147	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—JUN—bone cancer	2.35e-05	0.000145	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MMP9—bone cancer	2.28e-05	0.000141	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GSTP1—bone cancer	2.27e-05	0.00014	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GSTP1—bone cancer	2.27e-05	0.00014	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GNA11—bone cancer	2.25e-05	0.000139	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ENO2—bone cancer	2.18e-05	0.000135	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NT5C3A—bone cancer	2.17e-05	0.000134	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CYP3A4—bone cancer	2.16e-05	0.000133	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.15e-05	0.000133	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ENO2—bone cancer	2.05e-05	0.000127	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.05e-05	0.000127	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CYP3A4—bone cancer	2.04e-05	0.000126	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—DHFR—bone cancer	2.02e-05	0.000125	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ENO2—bone cancer	1.94e-05	0.00012	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—DHFR—bone cancer	1.9e-05	0.000118	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GNA11—bone cancer	1.89e-05	0.000117	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTP1—bone cancer	1.85e-05	0.000114	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EGFR—bone cancer	1.84e-05	0.000114	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—DHFR—bone cancer	1.8e-05	0.000111	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GNA11—bone cancer	1.78e-05	0.00011	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ENO2—bone cancer	1.77e-05	0.00011	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TGFBR2—bone cancer	1.75e-05	0.000108	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTP1—bone cancer	1.75e-05	0.000108	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.72e-05	0.000106	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CYP3A4—bone cancer	1.71e-05	0.000106	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GNA11—bone cancer	1.68e-05	0.000104	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—DHFR—bone cancer	1.65e-05	0.000102	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CYP3A4—bone cancer	1.61e-05	9.97e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—bone cancer	1.55e-05	9.57e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ENO2—bone cancer	1.55e-05	9.55e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GNA11—bone cancer	1.54e-05	9.51e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CYP3A4—bone cancer	1.52e-05	9.4e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.51e-05	9.35e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—bone cancer	1.47e-05	9.06e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ENO2—bone cancer	1.46e-05	9e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ENO2—bone cancer	1.44e-05	8.92e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—DHFR—bone cancer	1.43e-05	8.86e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP3A4—bone cancer	1.39e-05	8.62e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.39e-05	8.57e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—bone cancer	1.38e-05	8.53e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—DHFR—bone cancer	1.35e-05	8.35e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GNA11—bone cancer	1.34e-05	8.28e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—DHFR—bone cancer	1.34e-05	8.28e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—bone cancer	1.3e-05	8.04e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GNA11—bone cancer	1.26e-05	7.8e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GNA11—bone cancer	1.25e-05	7.74e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ENO2—bone cancer	1.23e-05	7.62e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP3A4—bone cancer	1.21e-05	7.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KIT—bone cancer	1.19e-05	7.38e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—bone cancer	1.19e-05	7.37e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—bone cancer	1.17e-05	7.25e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—bone cancer	1.17e-05	7.25e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP3A4—bone cancer	1.14e-05	7.08e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—DHFR—bone cancer	1.14e-05	7.07e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP3A4—bone cancer	1.13e-05	7.01e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.13e-05	6.98e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—bone cancer	1.12e-05	6.94e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GNA11—bone cancer	1.07e-05	6.61e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—bone cancer	1.04e-05	6.42e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—bone cancer	9.79e-06	6.05e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—bone cancer	9.71e-06	6e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP3A4—bone cancer	9.7e-06	5.99e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.65e-06	5.96e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—bone cancer	9.57e-06	5.91e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ENO2—bone cancer	9.52e-06	5.88e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MDM2—bone cancer	9.41e-06	5.81e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—bone cancer	9.05e-06	5.59e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—DHFR—bone cancer	8.83e-06	5.46e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—bone cancer	8.3e-06	5.13e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GNA11—bone cancer	8.26e-06	5.1e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—bone cancer	7.15e-06	4.42e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—bone cancer	6.74e-06	4.17e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—bone cancer	6.43e-06	3.97e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—bone cancer	6.4e-06	3.96e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—bone cancer	6.18e-06	3.82e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—bone cancer	5.38e-06	3.33e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—bone cancer	5.07e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—bone cancer	5.03e-06	3.11e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—bone cancer	4.3e-06	2.66e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—bone cancer	3.32e-06	2.05e-05	CbGpPWpGaD
